Physician profile
Frederick V Behm
NPI 1952413023
$611.08
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.48 · 2021: $86.17 · 2022: $284 · 2023: $107 · 2024: $85.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.58 | 2021-2023 | Orilissa, Lo Loestrin Fe |
| Organon LLC | $73.24 | 2021-2023 | Nexplanon |
| Hologic Sales and Service, LLC | $54.27 | 2022-2024 | Third Wave, Thinprep 2000 Processor, Aptima |
| Allergan, INC. | $49.48 | 2019 | |
| Astellas Pharma US INC | $41.00 | 2024 | Veozah |
| Myovant Sciences INC. | $23.31 | 2022 | |
| Exact Sciences Corporation | $16.74 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $16.09 | 2023 | Myfembree |
| Pfizer INC. | $15.19 | 2024 | |
| Avion Pharmaceuticals | $15.03 | 2022 | |
| Merck Sharp & Dohme LLC | $13.86 | 2021 | |
| Meditrina | $13.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Behm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.